Alpha Tau Medical Ltd (DRTS) - Product Pipeline Analysis, 2024 Update

Alpha Tau Medical Ltd (Alpha Tau) is medical technology company that focuses on the discovery, development and marketing of Alpha DaRT seed for the treatment of solid cancers. The company is evaluating Alpha DaRT therapy for the treatment of skin cancer, oral cavity cancer, head-and-neck cancer and breast cancer in clinical studies. It offers cancer treatment services. It is advancing its clinical trials at cancer centers in Canada, Israel, Japan, Russia and France. The company is also investigating DaRT in pre-clinical trials as a combination with chemotherapy to combat local and metastatic cancer. Alpha Tau Medical is headquartered in Tel Aviv, Israel.

This report is a source for data, analysis, and actionable intelligence on the company’s portfolio of pipeline products. The report provides key information about the company, its major products and brands.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage.

Scope:

The report reviews detailed company profile with information on business description, key company facts, major products and services, key competitors, key employees, locations and subsidiaries and recent developments
The report analyzes all pipeline products in development for the company Alpha Tau Medical Ltd
The report provides pipeline analysis on all pipeline products of the company (by equipment type, by indication, by development stage, and by trial status)
The report covers detailed information on each pipeline product with information on pipeline territory, stage of development, device class, regulatory path, indication(s), application(s) and estimated launch date
The report provides detailed description of products in development, technical specification and functions
The report also covers ongoing clinical trials (wherever applicable) with information on trial name, trial objective, sponsor, trial design, trial status and phase, estimated start and end date.

Reasons to Buy:

Develop business strategies by understanding the trends and developments driving the medical devices pipeline and technology landscape
Design and develop your product development, marketing and sales strategies by understanding the competitor portfolio
To formulate effective Research & Development strategies
Develop market-entry and market expansion strategies
Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return
Plan mergers and acquisitions effectively by identifying key players of the most promising pipeline
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
Develop competition strategies by identifying the status and likely launch of the competitors’ pipeline products through review of the clinical trials, stage and of development, etc
Identify, understand and capitalize the next high-value products that your competitor would add in its portfolio

Note: Some sections may be missing if data is unavailable for the company

Alpha Tau Medical Ltd Company Overview
Alpha Tau Medical Ltd Company Snapshot
Alpha Tau Medical Ltd Pipeline Products and Ongoing Clinical Trials Overview
Alpha Tau Medical Ltd - Pipeline Analysis Overview
Alpha Tau Medical Ltd - Key Facts
Alpha Tau Medical Ltd - Major Products and Services
Alpha Tau Medical Ltd Pipeline Products by Development Stage
Alpha Tau Medical Ltd Ongoing Clinical Trials by Trial Status
Alpha Tau Medical Ltd Pipeline Products Overview
Alpha DaRT Kit - Breast cancer
Alpha DaRT Kit - Breast cancer Product Overview
Alpha DaRT Kit - Breast cancer Clinical Trial
Alpha DaRT Kit - Cutaneous and Mucosal Neoplasia
Alpha DaRT Kit - Cutaneous and Mucosal Neoplasia Product Overview
Alpha DaRT Kit - Cutaneous and Mucosal Neoplasia Clinical Trial
Alpha DaRT Kit - Head And Neck Cancer
Alpha DaRT Kit - Head And Neck Cancer Product Overview
Alpha DaRT Kit - Head And Neck Cancer Clinical Trial
Alpha DaRT Kit - Liver Cancer
Alpha DaRT Kit - Liver Cancer Product Overview
Alpha DaRT Kit - Liver Cancer Clinical Trial
Alpha DaRT Kit - Neoadjuvant Rectal Cancer
Alpha DaRT Kit - Neoadjuvant Rectal Cancer Product Overview
Alpha DaRT Kit - Pancreatic Cancer
Alpha DaRT Kit - Pancreatic Cancer Product Overview
Alpha DaRT Kit - Pancreatic Cancer Clinical Trial
Alpha DaRT Kit - Prostate Cancer
Alpha DaRT Kit - Prostate Cancer Product Overview
Alpha DaRT Kit - Prostate Cancer Clinical Trial
Alpha DaRT Kit - Recurrent Cervical Cancer
Alpha DaRT Kit - Recurrent Cervical Cancer Product Overview
Alpha DaRT Kit - Recurrent Glioblastoma Multiforme
Alpha DaRT Kit - Recurrent Glioblastoma Multiforme Product Overview
Alpha DaRT Kit - Recurrent Gynecological Cancer
Alpha DaRT Kit - Recurrent Gynecological Cancer Product Overview
Alpha DaRT Kit - Recurrent Lung Cancer
Alpha DaRT Kit - Recurrent Lung Cancer Product Overview
Alpha DaRT Kit - Recurrent Lung Cancer Clinical Trial
Alpha DaRT Kit - Recurrent Prostate Cancer
Alpha DaRT Kit - Recurrent Prostate Cancer Product Overview
Alpha DaRT Kit - Recurrent Rectal Cancer
Alpha DaRT Kit - Recurrent Rectal Cancer Product Overview
Alpha DaRT Kit - Sarcoma
Alpha DaRT Kit - Sarcoma Product Overview
Alpha DaRT Kit - Skin Cancer
Alpha DaRT Kit - Skin Cancer Product Overview
Alpha DaRT Kit - Skin Cancer Clinical Trial
Alpha DaRT Kit - Squamous Cell Carcinoma
Alpha DaRT Kit - Squamous Cell Carcinoma Product Overview
Alpha DaRT Kit - Squamous Cell Carcinoma Clinical Trial
Alpha DaRT Kit - Vulvar Cancer
Alpha DaRT Kit - Vulvar Cancer Product Overview
Alpha DaRT Kit - Vulvar Cancer Clinical Trial
Alpha Tau Medical Ltd - Key Competitors
Alpha Tau Medical Ltd - Key Employees
Alpha Tau Medical Ltd - Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Recent Developments
Alpha Tau Medical Ltd, Recent Developments
Jun 25, 2024: Alpha Tau Announces Publication in Cancers Journal of Long-Term Safety and Efficacy Data in Multiple Hard-to-Treat Superficial Cancers
May 13, 2024: Alpha Tau Announces Alpha DaRT Treatment of First Patient with Liver Metastases of Colorectal Cancer
May 06, 2024: Alpha Tau Presents Preclinical Data Demonstrating Abscopal Immune Effect in Pancreatic Murine Tumor Models at ESTRO 2024 Congress in Glasgow
Nov 28, 2023: Alpha Tau Announces Highly Promising Interim Results from Safety and Feasibility Trial of Alpha DaRT Treatment of Advanced Pancreatic Cancer
Nov 20, 2023: Alpha Tau Submits to Japanese PMDA for Pre-Market Approval of Alpha DaRT in Patients with Recurrent Head and Neck Cancer
Sep 14, 2023: Alpha Tau Treats First Patient with Advanced Inoperable Pancreatic Cancer at Israel’s Hadassah Medical Center
Aug 28, 2023: Alpha Tau Medical Announces Second Quarter 2023 Financial Results and Provides Corporate Update
Aug 17, 2023: Alpha Tau Announces Robust Long-Term Safety and Efficacy Data from Multiple Clinical Trials of Alpha DaRT
May 24, 2023: Alpha Tau Medical to participate in June Investor Conferences
May 23, 2023: Alpha Tau Medical announces Q1 2023 financial results and provides corporate update
Appendix
Methodology
About the Analyst
Contact the Publisher
Disclaimer

List of Tables

Alpha Tau Medical Ltd Pipeline Products and Ongoing Clinical Trials Overview
Alpha Tau Medical Ltd Pipeline Products by Equipment Type
Alpha Tau Medical Ltd Pipeline Products by Indication
Alpha Tau Medical Ltd Ongoing Clinical Trials by Trial Status
Alpha Tau Medical Ltd, Key Facts
Alpha Tau Medical Ltd, Major Products and Services
Alpha Tau Medical Ltd Number of Pipeline Products by Development Stage
Alpha Tau Medical Ltd Pipeline Products Summary by Development Stage
Alpha Tau Medical Ltd Ongoing Clinical Trials by Trial Status
Alpha Tau Medical Ltd Ongoing Clinical Trials Summary
Alpha DaRT Kit - Breast cancer - Product Status
Alpha DaRT Kit - Breast cancer - Product Description
Alpha DaRT Kit - Breast cancer - A Pilot Feasibility and Safety Trial of Intratumoral Diffusing Alpha-emitter Radiation Therapy (DaRT) for the Treatment of Newly Diagnosed or Recurrent Breast Carcinoma in Frail or Elderly Patients
Alpha DaRT Kit - Cutaneous and Mucosal Neoplasia - Product Status
Alpha DaRT Kit - Cutaneous and Mucosal Neoplasia - Product Description
Alpha DaRT Kit - Cutaneous and Mucosal Neoplasia - A Safety and Effectiveness Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Malignant Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
Alpha DaRT Kit - Cutaneous and Mucosal Neoplasia - A Safety and Effectiveness Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Malignant Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
Alpha DaRT Kit - Cutaneous and Mucosal Neoplasia - A Safety and Effectiveness Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Malignant Cutaneous, Mucosal or Superficial Soft Tissue Neoplasia
Alpha DaRT Kit - Cutaneous and Mucosal Neoplasia - A Safety and Preliminary Effectiveness Study of Intratumoral Diffusing Alpha Radiation Emitters on Cutaneous, Mucosal and Superficial Soft Tissue Neoplasia
Alpha DaRT Kit - Head And Neck Cancer - Product Status
Alpha DaRT Kit - Head And Neck Cancer - Product Description
Alpha DaRT Kit - Head And Neck Cancer - A Study to Evaluate the Efficacy of Neoadjuvant DaRT for Locally Advanced Oral Cavity Squamous Cell Carcinoma
Alpha DaRT Kit - Liver Cancer - Product Status
Alpha DaRT Kit - Liver Cancer - Product Description
Alpha DaRT Kit - Liver Cancer - A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Liver Metastases
Alpha DaRT Kit - Neoadjuvant Rectal Cancer - Product Status
Alpha DaRT Kit - Neoadjuvant Rectal Cancer - Product Description
Alpha DaRT Kit - Pancreatic Cancer - Product Status
Alpha DaRT Kit - Pancreatic Cancer - Product Description
Alpha DaRT Kit - Pancreatic Cancer - A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Advanced Pancreatic Cancer
Alpha DaRT Kit - Pancreatic Cancer - A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Locally Advanced Pancreatic Cancer
Alpha DaRT Kit - Pancreatic Cancer - A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters on Advanced Pancreatic Cancer
Alpha DaRT Kit - Prostate Cancer - Product Status
Alpha DaRT Kit - Prostate Cancer - Product Description
Alpha DaRT Kit - Prostate Cancer - A Feasibility and Safety Study of Focal Interstitial Radiotherapy Using Diffusing Alpha Emitters Radiation Therapy (DaRT) Seeds in Men With Non-metastatic Locally Recurrent Prostate Cancer
Alpha DaRT Kit - Prostate Cancer - A Feasibility of Neoadjuvant Interstitial Brachytherapy (Ibt) Using Diffusing Alpha Emitters Radiation Therapy (Dart) Seeds in Men With Prostate Cancer
Alpha DaRT Kit - Recurrent Cervical Cancer - Product Status
Alpha DaRT Kit - Recurrent Cervical Cancer - Product Description
Alpha DaRT Kit - Recurrent Glioblastoma Multiforme - Product Status
Alpha DaRT Kit - Recurrent Glioblastoma Multiforme - Product Description
Alpha DaRT Kit - Recurrent Gynecological Cancer - Product Status
Alpha DaRT Kit - Recurrent Gynecological Cancer - Product Description
Alpha DaRT Kit - Recurrent Lung Cancer - Product Status
Alpha DaRT Kit - Recurrent Lung Cancer - Product Description
Alpha DaRT Kit - Recurrent Lung Cancer - A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Recurrent Lung Cancer
Alpha DaRT Kit - Recurrent Prostate Cancer - Product Status
Alpha DaRT Kit - Recurrent Prostate Cancer - Product Description
Alpha DaRT Kit - Recurrent Rectal Cancer - Product Status
Alpha DaRT Kit - Recurrent Rectal Cancer - Product Description
Alpha DaRT Kit - Sarcoma - Product Status
Alpha DaRT Kit - Sarcoma - Product Description
Alpha DaRT Kit - Skin Cancer - Product Status
Alpha DaRT Kit - Skin Cancer - Product Description
Alpha DaRT Kit - Skin Cancer - A Prospective International Multicenter, Pivotal, Single Arm, Open Label Clinical Study to Assess the Efficacy and Safety of Intratumoral Alpha DaRT224 for the Treatment of Patients with Recurrent Cutaneous Squamous Cell Carcinoma
Alpha DaRT Kit - Skin Cancer - A Safety and Effectiveness Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Malignant Cutaneous Tumors
Alpha DaRT Kit - Squamous Cell Carcinoma - Product Status
Alpha DaRT Kit - Squamous Cell Carcinoma - Product Description
Alpha DaRT Kit - Squamous Cell Carcinoma - A Safety and Efficacy Study of Intratumoral Diffusing Alpha Radiation Emitters in Recurrent Unresectable or Metastatic Head and Neck Squamous Cell Carcinoma
Alpha DaRT Kit - Vulvar Cancer - Product Status
Alpha DaRT Kit - Vulvar Cancer - Product Description
Alpha DaRT Kit - Vulvar Cancer - A Feasibility and Safety Study of Intratumoral Diffusing Alpha Radiation Emitters for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva
Alpha DaRT Kit - Vulvar Cancer - A Safety and Efficacy Study of Intra-tumoural Diffusing Alpha Radiation Emitters (DaRT) for the Treatment of Primary and Recurrent Squamous Cell Carcinoma of the Vulva
Alpha Tau Medical Ltd, Key Employees
Alpha Tau Medical Ltd, Other Locations
Alpha Tau Medical Ltd, Subsidiaries
Glossary

List of Figures

Alpha Tau Medical Ltd Pipeline Products by Equipment Type
Alpha Tau Medical Ltd Pipeline Products by Development Stage
Alpha Tau Medical Ltd Ongoing Clinical Trials by Trial Status

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

Technion Technology Transfer
Fore Biotherapeutics Inc
Champions Oncology (Israel) Limited